[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652412":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":52,"collaborators":25,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":25,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":25,"enrollmentInfo":65,"targetDuration":25,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":25,"overallStatus":39,"whyStopped":25,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of Monastir","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Telemonitoring Group","EXPERIMENTAL","Participants in the telemonitoring group receive a connected blood glucose meter, which automatically transmits all blood glucose readings to a dedicated online telemonitoring platform.",[13],"Device: Telemonitoring group",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Care Group","ACTIVE_COMPARATOR","Participants in the usual care group will receive standard diabetes management according to routine clinical practice, at the discretion of their treating physicians. The standard follow-up will include at least three scheduled study visits at Day 15, Month 3, and Month 6. The same clinical and study data will be collected at each visit as in the telemonitoring group.",[19],"Other: Usual Care Group",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DEVICE","Telemonitoring group",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Usual Care Group","Standard follow-up will including at least three scheduled study visits at Day 15, Month 3, and Month 6.",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Nouira Semir","CONTACT","0021673106046","semir.nouira@rns.tn",[37],{"facility":38,"status":39,"city":40,"state":25,"zip":25,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"University Hospital Fattouma Bourguiba Monastir","RECRUITING","Monastir","Tunisia","TN",{"type":44,"coordinates":45},"Point",[46,47],10.82617,35.77799,{"lat":47,"lon":46},[50],{"name":51,"role":33,"phone":34,"phoneExt":25,"email":35},"Nouira Semir, Professor",{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Pr. Semir Nouira","Professor","100652412","effectiveness-and-utility-of-telemonitoring-in-improving-the-glycaemic-control-of-diabetes-mellitus-tunisian-patients-100652412",false,"NCT07774078","Effectiveness and Utility of Telemonitoring in Improving the Glycaemic Control of Diabetes Mellitus Tunisian Patients","Evaluation of the Effectiveness and Utility of Telemonitoring in Improving the Glycaemic Control of Tunisian Patients With Diabetes Mellitus: a Study Protocol","Inclusion Criteria:\n\n* Diagnosis of diabetes mellitus with HbA1c between 7% and 10%.\n* Stable antidiabetic treatment for at least 4 weeks prior to enrollment.\n\nExclusion Criteria:\n\n* Serum creatinine \\>200 µmol\u002FL.\n* Acute coronary syndrome or stroke.\n* Dementia.\n* Pregnancy.\n* Inability to participate in or comply with the telemonitoring intervention.\n* Severe diabetic retinopathy.","ALL","18 Years",{"count":66,"type":67},260,"ESTIMATED","INTERVENTIONAL",[70],"NA","The study aims to evaluate the impact of a telemonitoring system on glycemic control in patients with diabetes in Tunisia. Participants in the intervention group will receive remote diabetes management through a dedicated mobile application and web platform, while the control group will receive standard diabetes care. The primary objective is to determine the effectiveness of telemonitoring in improving glycemic control, as assessed by changes in glycated hemoglobin (HbA1c) and blood glucose levels.",[73,74],"Diabete Mellitus","Telemonitoring","2026-08-19",{"date":77,"type":78},"2026-08-20","ACTUAL",{"date":80,"type":78},"2024-08-01",{"date":82,"type":67},"2026-12-31",{"name":5,"class":6},1]